t cells

Why Children May Experience Mild COVID-19

Compared to adults, children with COVID-19 have a lower T cell response, possibly leading to mild or asymptomatic infections.

How T-cells Tip COVID-19 From Mild To Severe

According to scientists from Japan, the difference between mild and severe cases of COVID-19 may lie in the extreme activation of T-cells as they react to the SARS-CoV-2 virus.

Some Uninfected People Have T-Cell Immunity To COVID-19

Researchers were surprised to find memory T-cells in people with no history of SARS, COVID-19, or contact with SARS or COVID-19 patients.

Predicting Which Cells Can Take The BiTE Out Of Cancer

Using bispecific T-cell engager technology, or BiTE, researchers in Japan have found that the cancer-killing activity of T-cells in tumors can be estimated from T-cells in the blood.

Immune Cell ‘Handshake’ Can Kill Dengue Virus

The interaction between two types of immune cells—mast cells and γδ T cells—is necessary for fighting dengue infection, say researchers from Singapore.

Scientists Find Regulatory T-Cell Master Switch

Researchers in South Korea have identified Foxp1 as a key molecule required for the formation of regulatory T-cells.

Tasuku Honjo Wins 2018 Nobel Prize in Physiology or Medicine

Professor Tasuku Honjo was recognized for his discovery of PD-1, which paved the way for modern cancer immunotherapy.

Prolonged Immune Activation Changes Behavior In Mice

Scientists in Japan have demonstrated that the prolonged activation of immune cells affects the production of neurotransmitters in the brain, leading to behavioral changes.

Immune Cells In A Tug Of War For Survival

To survive and maintain immune memory, T-cells need to compete with innate lymphoid cells for a key protein called IL-7.

Takeda Invests US$125 Million In Maverick’s T-Cell Platform

Maverick Therapeutics Inc. and Takeda will collaborate to develop a biologics platform for T-cell immunotherapy over the next five years.